EPA faces suit over plan to release genetically engineered mosquitoes
By Rachel Franzin,
The Hill
| 06. 15. 2020
The Center for Food Safety, the International Center for Technology Assessment and Friends of the Earth allege that the EPA violated the law.
The Environmental Protection Agency (EPA) is facing a lawsuit over its approval of a plan to release genetically modified mosquitoes in Florida and Texas.
Several groups, including the Center for Food Safety, the International Center for Technology Assessment and Friends of the Earth filed a notice of intent to sue on Friday. They alleged that the EPA violated the law by failing to consult with wildlife agencies before determining that the mosquitoes will not pose risks to threatened species.
“EPA’s ‘no effect’ findings and failure to consult are arbitrary and capricious and violate the ESA [Endangered Species Act] because they fail to follow the ESA’s mandated procedures, fail to use the best scientific and commercial data available, fail to consider significant aspects of the issue, and offer an explanation that runs counter to the evidence before the agency,” the groups claimed in their notice.
The EPA last month approved an experimental use permit for a company that wants to test the use of genetically engineered mosquitoes as a way to try to reduce mosquito populations and protect people from mosquito-borne illnesses.
According...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...